Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released Nov 7, 2017, after the close
10-Q filed Nov 7, 2017, 38 days after period end · 0001564590-17-022271
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Revenue | $35.58M | $5.27M | $39.00K | $15.00K |
| Net Income | -$65.25M | -$71.61M | -$38.91M | -$24.79M |
| EPS Diluted |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.53 |
| -$0.61 |
| -$0.39 |
| -$0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
